Regulatory-Grade RWE Platforms for FDA & EMA Submissions
Learn how pharma companies build regulatory-grade real-world evidence (RWE) platforms using real-world data for FDA and EMA drug development submissions.
Back to Articles
Articles tagged with “real-world-data”
AI Patient Recruitment for Clinical Trials: Platform Guide
Review AI patient recruitment platforms for clinical trials. Compare EHR integration, federated networks, and patient-facing software for trial matching.
AI in RWE Studies: Applications, Challenges & Impact
Learn how AI and machine learning analyze Real-World Data (RWD) to generate Real-World Evidence (RWE). Explore key applications including LLM-driven data extraction, pharmacovigilance, and synthetic control arms, plus 2025-2026 FDA and EMA regulatory updates.
Real-World Evidence: A Guide to RWE Analysis & Application
Explore the state of Real-World Evidence (RWE) analysis in 2025-2026. This guide covers RWD sources, analytical methods, FDA/EMA regulatory frameworks, ICH E6(R3), synthetic control arms, AI-driven RWE platforms, and compares RWE with RCTs
Guide to Pharmacovigilance Technology & AI in Drug Safety
Updated 2026 guide to pharmacovigilance technology covering GenAI/LLMs in PV, AI-powered case processing, signal detection, FDA-EMA AI guidance, and data standards for drug safety
Target Trial Emulation: A Framework for Causal RWE
Learn how target trial emulation provides a structured framework for drawing causal inference from real-world evidence (RWE), with 2025 updates on the TARGET reporting guideline, ICH M14, and FDA guidance.